INDIRECT COMPARISIONS PRESENTED IN GERMAN BENEFIT ASSESSMENTS - STATUS QUO AND QUO VADIS?

被引：0
|
作者：
Kreisor, M. [1 ]
Schiffter-Weinle, H. A. [1 ]
Boehler, Y. [1 ]
机构：
[1] Univ Appl Sci, TH Koeln, Leverkusen, Germany
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.1778
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP242
引用
收藏
页码：A694 / A694
页数：1
相关论文
共 50 条
  • [1] The status quo and quo vadis of mast cells
    Maurer, M
    Metz, M
    EXPERIMENTAL DERMATOLOGY, 2005, 14 (12) : 923 - 929
  • [2] Vancomycin Resistance: Status Quo and Quo Vadis
    H. P. Endtz
    N. van den Braak
    H. A. Verbrugh
    A. van Belkum
    European Journal of Clinical Microbiology and Infectious Diseases, 1999, 18 : 683 - 690
  • [3] Vancomycin resistance: Status quo and quo vadis
    Endtz, HP
    van den Braak, N
    Verbrugh, HA
    van Belkum, A
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1999, 18 (10) : 683 - 690
  • [4] Genetics of Anxiety Disorders - Status Quo and Quo Vadis
    Domschke, Katharina
    Deckert, Juergen
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (35) : 5691 - 5698
  • [5] PET imaging of gliomas: Status quo and quo vadis?
    Galldiks, Norbert
    Lohmann, Philipp
    Friedrich, Michel
    Werner, Jan-Michael
    Stetter, Isabelle
    Wollring, Michael M.
    Ceccon, Garry
    Stegmayr, Carina
    Krause, Sandra
    Fink, Gereon R.
    Law, Ian
    Langen, Karl-Josef
    Tonn, Joerg-Christian
    NEURO-ONCOLOGY, 2024,
  • [6] DGGG Guidelines Programme: Status Quo - Quo Vadis!
    Beckmann, M. W.
    Linde, I.
    Buetof, C.
    Kreienberg, R.
    Gass, P.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2014, 74 (03) : 251 - 259
  • [7] Aspirin in essential thrombocythemia: Status quo and quo vadis
    Griesshammer, M
    Bangerter, M
    Van Vliet, HHDM
    Michiels, JJ
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1997, 23 (04): : 371 - 377
  • [8] ONCOLOGICAL COMBINATION THERAPIES IN THE CONTEXT OF THE EARLY BENEFIT ASSESSMENT ACCORDING TO AMNOG: STATUS QUO AND QUO VADIS
    Fisenkci, N.
    Boehler, Y. B.
    VALUE IN HEALTH, 2023, 26 (12) : S365 - S366
  • [9] Rheumatology in the digital health era: status quo and quo vadis?
    Knitza, Johannes
    Gupta, Latika
    Hugle, Thomas
    NATURE REVIEWS RHEUMATOLOGY, 2024, 20 (12) : 747 - 759
  • [10] Collaborative business process management: status quo and quo vadis
    Niehaves, Bjoern
    Plattfaut, Ralf
    BUSINESS PROCESS MANAGEMENT JOURNAL, 2011, 17 (03) : 384 - 402
12345